MedCity News June 5, 2024
Katie Adams

CoraVie Medical, a startup developing an implantable continuous blood pressure monitor, recently won the medical devices track of MedCity News’ INVEST Pitch Perfect contest. The pre-revenue company’s remote management solution monitors for the early detection of dangerous blood pressure levels to prevent crises that could lead to heart attack, stroke, kidney failure or death.

To Aimee Garza, it’s no wonder hypertension remains one of the most prevalent yet most uncontrolled conditions in the U.S., costing the country about $131 to $198 billion each year. This is because the fundamental approach to blood pressure monitoring has not changed in “literally over a century,” she pointed out in an interview.

Garza serves as CEO of CoraVie Medical, a Minneapolis-based startup seeking to...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Investments, Medical Devices, Trends
UN warns of military brain control
Only 20% of AI devices for children used pediatric data to train: 3 notes
Medtech firms have cut thousands of jobs this year. Will layoffs continue in 2025?
Proton therapy market in the US projected to reach $2.67 billion by 2033
How Trump’s second term will affect the medtech industry

Share This Article